Keyron

Keyron is a UK-based preclinical stage medical device and technology platform company aimed at efficiently treating metabolic diseases. Keyron's patented ForePass™ is an innovative medical device designed to safely reverse type 2 diabetes, as well as NASH and obesity. The company has already demonstrated complete reversal of insulin resistance in animal experiments and recently published the research results in The Lancet eBioMedicine.